《环球时报》：多西环素-治疗革兰氏阴性败血症的新瓶装老酒。

IF 1 Q4 INFECTIOUS DISEASES

Journal of Global Infectious Diseases Pub Date : 2023-08-30 eCollection Date: 2023-07-01 DOI:10.4103/jgid.jgid_139_23

Tanmoy Ghatak, Reuben W Holland

{"title":"《环球时报》：多西环素-治疗革兰氏阴性败血症的新瓶装老酒。","authors":"Tanmoy Ghatak, Reuben W Holland","doi":"10.4103/jgid.jgid_139_23","DOIUrl":null,"url":null,"abstract":"The modern medicine era is undergoing a pandemic of “antibiotic resistance.” The multidrug‐resistant (MDR) Gram‐negative organisms are hitting the most harm. While gasping in this sinking scenario, our best bet is either to search for new promising powerful antibiotics or to resharpen the old ones. As the development promise of newer antibiotics is not vibrant, the restoration of previously invented but abandoned “old” antibiotics is routine.[1] Moreover, the new uses of old antibiotics are also in game.","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/01/b2/JGID-15-93.PMC10549898.pdf","citationCount":"0","resultStr":"{\"title\":\"State of the Globe: Doxycycline - An Old Wine in a New Bottle for Gram-Negative Sepsis.\",\"authors\":\"Tanmoy Ghatak, Reuben W Holland\",\"doi\":\"10.4103/jgid.jgid_139_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The modern medicine era is undergoing a pandemic of “antibiotic resistance.” The multidrug‐resistant (MDR) Gram‐negative organisms are hitting the most harm. While gasping in this sinking scenario, our best bet is either to search for new promising powerful antibiotics or to resharpen the old ones. As the development promise of newer antibiotics is not vibrant, the restoration of previously invented but abandoned “old” antibiotics is routine.[1] Moreover, the new uses of old antibiotics are also in game.\",\"PeriodicalId\":51581,\"journal\":{\"name\":\"Journal of Global Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2023-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/01/b2/JGID-15-93.PMC10549898.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Global Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jgid.jgid_139_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Global Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jgid.jgid_139_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

State of the Globe: Doxycycline - An Old Wine in a New Bottle for Gram-Negative Sepsis.

The modern medicine era is undergoing a pandemic of “antibiotic resistance.” The multidrug‐resistant (MDR) Gram‐negative organisms are hitting the most harm. While gasping in this sinking scenario, our best bet is either to search for new promising powerful antibiotics or to resharpen the old ones. As the development promise of newer antibiotics is not vibrant, the restoration of previously invented but abandoned “old” antibiotics is routine.[1] Moreover, the new uses of old antibiotics are also in game.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Global Infectious Diseases INFECTIOUS DISEASES-

CiteScore

3.30

自引率

0.00%

发文量

审稿时长

29 weeks

期刊介绍： JGID encourages research, education and dissemination of knowledge in the field of Infectious Diseases across the world thus promoting translational research by striking a synergy between basic science, clinical medicine and public health. The Journal intends to bring together scientists and academicians in Infectious Diseases to promote translational synergy between Laboratory Science, Clinical Medicine and Public Health. The Journal invites Original Articles, Clinical Investigations, Epidemiological Analysis, Data Protocols, Case Reports, Clinical Photographs, review articles and special commentaries. Students, Residents, Academicians, Public Health experts and scientists are all encouraged to be a part of this initiative by contributing, reviewing and promoting scientific works and science.